Ingrid Kummer

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Identifying self-assessed competencies and areas for improvement within community pharmacist-preceptors support during pre-registration training

Margita Držaić, Ingrid Kummer, Iva Mucalo et al. · BMC Medical Education · 2018 · 31 citations · Full text

Clinical decision‐making in benzodiazepine deprescribing by healthcare providers <i>vs</i>. AI‐assisted approach

Iva Bužančić, Dora Belec, Margita Držaić et al. · British Journal of Clinical Pharmacology · 2023 · 23 citations · Full text

Artificial Intelligence, Clinical Decision-making, Clinical Decision‐making +19

Polypharmacy and potentially inappropriate prescribing of benzodiazepines in older nursing home residents

Ingrid Kummer, Jindra Reissigová, Anna Lukačišinová et al. · Annals of Medicine · 2024 · 11 citations · Full text